Source: European Medicines Agency (EU) Revision Year: 2020 Publisher: Amryt GmbH, Streiflingsweg 11, 75223 Niefern-Öschelbronn, Germany tel +49 (0) 7233 9749 0 fax +49 (0) 7233 9749 – 210 Email: info.de@amrytpharma.com
Episalvan gel.
Pharmaceutical Form |
---|
Gel. Colourless to slightly yellowish, opalescent. |
1 g gel contains: 100 mg extract (as dry extract, refined) from birch bark from Betula pendula Roth, Betula pubescens Ehrh. as well as hybrids of both species (equivalent to 0.5-1.0 g birch bark), corresponding to 72-88 mg betulin.
Extraction solvent: n-Heptane
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Betulin |
Betulin accelerated re-epithelialization in an in vitro wound scratch assay using human primary keratinocytes at the dosage of 1 μg/ml, and in a porcine ex vivo wound healing model at the dosage of 10 µg/ml. The precise mechanism of action of the active substance in wound healing in humans is not known. |
List of Excipients |
---|
Sunflower oil, refined. |
White collapsible aluminium tube, interior lacquered with epoxy phenolic coating, and with a sealing compound in the fold. The tubes are closed with a tamper-evident aluminium membrane and fitted with a white polypropylene screw cap. The tube is packed in a cardboard box.
Pack size: 1 tube containing 23.4 g gel.
Amryt GmbH, Streiflingsweg 11, 75223 Niefern-Öschelbronn, Germany
tel +49 (0) 7233 9749 – 0
fax +49 (0) 7233 9749 – 210
Email: info.de@amrytpharma.com
EU/1/15/1069/001
Date of first authorisation: 14 January 2016
Drug | Countries | |
---|---|---|
EPISALVAN | Estonia, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.